Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  News  >  Companies

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

SAP drags down German shares, COVID-19 worries weigh on broader Europe

10/26/2020 | 12:13pm EST
FILE PHOTO: The German share price index DAX graph at the stock exchange in Frankfurt

(Reuters) - German shares closed at their lowest in nearly four months on Monday as Europe's most valuable tech firm, SAP, experienced its worst trading day in 24 years after cutting its 2020 outlook.

The German DAX fell 3.7% as SAP slumped almost 22% after abandoning medium-term profitability targets and cautioning that its business would take longer than expected to recover from the pandemic hit.

"SAP's pessimism does not bode well for hopes for the global economic recovery to continue," said Edward Moya, senior market analyst at OANDA, New York.

"If tech goes, the deteriorating outlook due to virus spread will likely yield massive risk aversion as investors head for the sidelines instead of rotating into cyclicals."

The wider European tech index <.SX8P> slid 7.4%.

SAP's results came as a blip in the third-quarter earnings season, which has been largely better than feared.

Meanwhile, fresh COVID-19-induced restrictions in Italy and Spain to curb a resurgence in cases weighed on the rest of Europe, with the pan-European STOXX 600 index closing at a one-month low, down 1.8%.

Europe on Saturday became the second region after Latin America to surpass 250,000 deaths, according to a Reuters tally.

The euro zone blue-chip index <.STOXX50E> fell nearly 3%, while Europe's travel and leisure sector, worst hit by the movement curbs, was down 3.3%.

Nick Nelson, head of European equity strategy at UBS, said the Swiss bank's target for STOXX 600 into the year-end is 340 points, about 4.5% below the current level, in part due to the impact of the latest round of restrictions.

Surveys of euro zone purchasing managers last week showed economic activity slipped back into decline in October, heightening expectations for a double-dip recession as a second wave of virus sweeps across the continent.

Globally, risk appetite was sapped by worries over slow progress on a new U.S. stimulus bill and a looming presidential election. [MKTS/GLOB]

Milan's blue-chip index fell 1.8% even as ratings agency Standard and Poor's upgraded Italy's sovereign outlook to stable from negative.

Oil majors Total and Royal Dutch Shell fell over 2.8% as crude prices slumped more than 3% on demand worries. [O/R]

Healthcare stocks remained supportive, with AstraZeneca gaining 1.7% after it resumed the U.S. trial of its experimental COVID-19 vaccine.

French stocks dipped 1.9%. Turkish leader Tayyip Erdogan asked his compatriots to stop buying French goods on Monday in the latest expression of anger in the Muslim world over images being displayed in France of the Prophet Mohammad, which some Muslims consider blasphemous.

(Reporting by Sruthi Shankar in Bengaluru; Editing by Sriraj Kalluvila and Emelia Sithole-Matarise)

By Sruthi Shankar and Susan Mathew

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 1.26% 7937 Delayed Quote.4.34%
DAX 0.00% 13313.24 Delayed Quote.0.48%
LONDON BRENT OIL 0.29% 48.08 Delayed Quote.-27.74%
ROYAL DUTCH SHELL PLC 2.76% 15.134 Delayed Quote.-42.16%
SAP SE 0.08% 101.3 Delayed Quote.-15.81%
STOXX EUROPE 600 -0.05% 391.69 Delayed Quote.-5.76%
TOTAL SE 1.05% 36.71 Real-time Quote.-25.39%
UBS GROUP AG -0.88% 12.89 Delayed Quote.5.44%
WTI 0.42% 45.06 Delayed Quote.-26.33%
Latest news "Companies"
01:33aK+S : Kepler Cheuvreux maintains a Buy rating
01:33aNESTLE MALAYSIA : Nestlé Malaysia Unveils NESCAFÉ Classic Kopi Kedah
01:31aSKANSKA : sells office building in Warsaw, Poland, for EUR 70 M, about SEK 720 M
01:31aMAGNOLIA BOSTAD : has acquired land in Ystad for developing housing and a school
01:31aXLIFE SCIENCES AG : Xlife Sciences expands its project portfolio
01:31aNORDEX GROUP : Successful EUR 200 million capital increase supports long-term growth path
01:31aONDERZOEKER RENEE NOORTMAN : “Ik geloof dat we de kwaliteit van leven echt kunnen gaan verbeteren door meer monitoring en betere preventie”
01:30aSANOMA OYJ : has signed a new EUR 200 million term loan
01:30aGERRESHEIMER AG : Receives a Sell rating from Kepler Cheuvreux
01:29aABN AMRO BANK : MeesPierson takes on more investment portfolio risk for 2021
Latest news "Companies"